Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Zanetta

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Proliferative response of lymphocytes from ovarian cancer patients to autologous tumor cellsP Allavena, P Lo Presti, M Di Bello, et al.
Transplantation Proceedings|April 1, 1995
Azathioprine-induced pancytopenia in homozygous thiopurine methyltransferase-deficient renal transplant recipients: a family studyA Escousse, C Mousson, L Santona, et al.
Birth (Berkeley, Calif.)|February 3, 2000
Changes in cesarean delivery in an Italian university hospital, 1982-1996: a comparison with the national trendG Zanetta, A Tampieri, I Currado, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin BD Caillot, P Chavanet, O Casasnovas, et al.
American Journal of Obstetrics and Gynecology|November 1, 1996
Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: its importance in long-term survivalG Zanetta, G L Keeney, S S Cha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group studyJ B Vermorken, G Zanetta, C F De Oliveira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2006
Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervixI F van Luijk, C Coens, M E L van der Burg, et al.
Clinical & Experimental Metastasis|August 5, 2000
Phenotypic and functional characteristics of tumour-derived microvascular endothelial cellsG Alessandri, R G Chirivi, S Fiorentini, et al.
Gynecologic Oncology|May 24, 2001
Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of CancerH C Wagenaar, N Colombo, I Vergote, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Proliferative response of lymphocytes from ovarian cancer patients to autologous tumor cellsP Allavena, P Lo Presti, M Di Bello, et al.
Transplantation Proceedings|April 1, 1995
Azathioprine-induced pancytopenia in homozygous thiopurine methyltransferase-deficient renal transplant recipients: a family studyA Escousse, C Mousson, L Santona, et al.
Birth (Berkeley, Calif.)|February 3, 2000
Changes in cesarean delivery in an Italian university hospital, 1982-1996: a comparison with the national trendG Zanetta, A Tampieri, I Currado, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin BD Caillot, P Chavanet, O Casasnovas, et al.
American Journal of Obstetrics and Gynecology|November 1, 1996
Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: its importance in long-term survivalG Zanetta, G L Keeney, S S Cha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group studyJ B Vermorken, G Zanetta, C F De Oliveira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2006
Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervixI F van Luijk, C Coens, M E L van der Burg, et al.
Clinical & Experimental Metastasis|August 5, 2000
Phenotypic and functional characteristics of tumour-derived microvascular endothelial cellsG Alessandri, R G Chirivi, S Fiorentini, et al.
Gynecologic Oncology|May 24, 2001
Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of CancerH C Wagenaar, N Colombo, I Vergote, et al.
Pageof 9